April 9, 2024 Stanford doctors help develop first FDA-approved gene-editing treatment The Food and Drug Administration (FDA) approved the gene therapy Casgevy in December, which uses CRISPR/Cas9 genome editing technology to treat sickle-cell disease (SCD)…
